GILD · News · 20261105N

Acquisition-Related R&D Charges

GILEAD SCIENCES, INC. · 2026-11-05 · Importance 28 · Surprise 42

Gilead outlined a larger projected GAAP loss tied to sizeable acquired research and development charges. The digest does not quantify the charges, identify the acquired program, or provide a comparison with prior-period charges. The reported effect was on projected GAAP results rather than the stated third-quarter revenue of US$8.3 billion.

Key facts

• Gilead outlined a larger projected GAAP loss tied to acquired R&D charges; the digest gives no loss or charge amount. source